ArticleBMC public health2025
Evaluation of the acceptability of ESIDA app, a smartphone-based clinical decision support application to improve infectious disease outbreak detection in Tanzania: clinician perspectives.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Barriers associated with the implementation, adoption, scale-up and sustainability of mHealth in Sub-Saharan Africa: a systematic review guided by the NASSS Framework.BMJ health & care informatics · 2026Pooled it
- Early diagnosis and treatment of leptospirosis: Optimizing clinical outcomes.The Journal of infection · 2026Review
- Systematic Evaluation of Utility and Usability of Publicly Available Mobile Apps for the Early Detection and Monitoring of Infectious Diseases.Journal of medical systems · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundEpidemic-prone infectious diseases (EPIDs) such as dengue fever, coronavirus disease 2019 (COVID-19), leptospirosis, Marburg virus disease, measles and cholera, to name a few, place a significant burden on the Tanzanian population and health system. Clinicians working in primary health facilities (PHFs), such as dispensaries, health centres, and basic hospitals, play a vital role in detecting cases and outbreaks. However, they often face challenges, including insufficient knowledge of these diseases and a lack of supporting resources, including surveillance guidelines, standard case definitions, and, most importantly, access to confirmatory diagnostic tests. Although Tanzania reports outbreaks of infectious diseases almost every year, a significant number of cases go undetected and contribute to delayed response and recurrent outbreaks. Smartphone-based clinical diagnostic decision support systems (CDSS) have been proven to help bridge case detection gaps. The Epidemiological Surveillance for Infectious Diseases in Sub-Saharan Africa (ESIDA) project proposed developing the ESIDA app, a smartphone-based CDSS, to aid clinicians in the detection of EPIDs. Before developing the app, the ESIDA project evaluated its acceptability among clinicians, the primary target users. The aim was to gather insights to inform the app development, ensuring its design and features are relevant and applicable in Tanzania context.
methodsIn-depth interviews were conducted with 21 clinicians, including medical doctors and clinical officers from public and private facilities in the Dar es Salaam region, which has reported frequent outbreaks of dengue and cholera. Data were collected and analyzed using the Unified Theory of Acceptance and Use of Technology (UTAUT) model.
resultClinicians were positive about the proposed ESIDA app and intended to use it once it was available. The facilitators and barriers to acceptability focused on performance expectancy, effort expectancy, facilitating conditions and social influence. Expected benefits, ease of use, and government involvement emerged as facilitators of acceptability, while high internet costs, workload, time constraints, infrastructure gaps, and patient resistance were identified as potential barriers.
conclusionThe development of the ESIDA app should prioritize maximizing system performance and benefits. They must also be user-friendly and in line with social norms. The necessary infrastructure must be in place for effective implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.